Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Operating Income (2025 - 2026)

Updated

Revium Rx's Operating Income was -$732,000 in Q2 2026.

Analysis

Revium Rx (RVRC) Operating Income (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 6.18 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.43 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 3.16 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.27 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - -732,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -732,000.00
Jun 30, 2025 -938,000.00
API Access

Revium Rx Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=RVRC&period=max&api_key=YOUR_API_KEY